Robert Paarlberg, MS

Regulatory Intelligence & Clinical Trial Disclosure / Transparency Advisor

Robert Paarlberg, MS in Analytical Chemistry, has more than 45 years of pharmaceutical industry experience in US and international regulatory affairs. Bob has expert knowledge and expertise in global regulatory policy and intelligence as well as global clinical trial disclosure and transparency. He has a proven track record in advancing corporate regulatory policy and strategy as well as organizing and managing a global clinical trial disclosure and transparency function.

Bob began his career in the pharmaceutical industry working in various aspects of US and international regulatory affairs including IND, ANDA, NDA and BLA submissions to the FDA. He created and managed one of the industry’s first global regulatory policy and intelligence functions.

Bob has been actively engaged in the global clinical trial disclosure and transparency landscape since 2005. He is well recognized for his expertise in this constantly evolving ecosystem.

Since 2010, Bob has provided consulting services to various biopharma companies specializing in regulatory intelligence and global clinical trial disclosure strategy and operations. He is a frequent speaker at clinical trial disclosure conferences.